xinhua
xinhua

NEWS CENTER

/
/
/
Five major trends in the future development of the healthcare industry

Five major trends in the future development of the healthcare industry

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2019-04-22 12:10
  • Views:
  • (Summary description)With the continuous reform of real estate and the saturation of the market, many people are looking for new investment directions, such as the medical industry. In recent years, the accumulation of established investment institutions and cutting-edge investment institutions has brought high valuations in the medical and health fields (especially medicines).

    Five major trends in the future development of the healthcare industry

    (Summary description)With the continuous reform of real estate and the saturation of the market, many people are looking for new investment directions, such as the medical industry. In recent years, the accumulation of established investment institutions and cutting-edge investment institutions has brought high valuations in the medical and health fields (especially medicines).

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2019-04-22 12:10
  • Views:
  • Information

    With the continuous reform of real estate and the saturation of the market, many people are looking for new investment directions, such as the medical industry. In recent years, the accumulation of established investment institutions and cutting-edge investment institutions has brought high valuations in the medical and health fields (especially medicines).

     

     

    The professional investment companies in the industry have come up with five major predictions on how the health care industry will develop in the future, and have certain reference value for potential investors:

     

    There is huge room for profit from rare disease drugs.

     

    Today, both chronic diseases and syndromes are becoming a new focus of attention. This is mainly because of the rare disease treatment "money" Jing Guangming: the competition in this field is smaller, the existing treatment methods are less, and continuous treatment is needed. In the road show special of Hengqin Medical and Health Forum, a company based on the research and development of new peptide drugs will provide financing for a peptide raw material drug and preparation project + new drug development and production project. If its peptide drug is successfully marketed, it will become the first drug in China to treat drug-resistant Gram-negative bacteria. The drug has achieved excellent results in preclinical experiments.

     

     

    Mergers and acquisitions.

     

    The $17 billion best-selling drug patent will expire in the next decade. Because the development of new drugs is both costly and time consuming, and the results are uncertain, although drug development will not stagnate, more and more pharmaceutical companies will be more likely to grow and expand through mergers and acquisitions. According to the person in charge of the Hengqin Medical Forum, a biotech company in Zhuhai will conduct a financing demonstration on the road show to acquire a 100% stake in a bio-pharmaceutical company. It is predicted that the target company's output value will increase by 5.7 times in the next three years.

     

    A new breakthrough in technology has been achieved in several areas.

    Of particular interest are CAR-T therapy and CPISPR-CAS9 gene editing. The application of blockchain technology in the healthcare sector is also worth looking forward to and worth observing because it allows patients to control their personal medical data more autonomously. On the one hand, the commercialization of life science technology related to the field of genes has appeared in many fields such as cancer precision treatment; on the other hand, the Internet medical industry chain has basically taken shape, and many domestic enterprises have undergone medical reform throughout China. In the big change, we will create a new model of medical services in the Internet era, build a large medical industry value sharing platform, and provide personalized medical services for patients. In this year's Hengqin Medical and Health Forum comprehensive project special project will also present immune cell reinfusion and storage projects and several smart medical health service platform projects, featuring genetic testing and "Internet +" coverage of all medical processes, creating a new The medical service model has achieved new breakthroughs in the treatment of serious diseases such as cancer.

     

    Generic drugs increased.

     

    The US FDA is likely to introduce more preferential policies to encourage the listing of generic drugs. This means that more generic drugs will be approved for listing and prices will fall accordingly. This trend may force traditional pharmaceutical companies with branded over-the-counter drugs to innovate, or their brand loyalty may be eroded. Among them, the domestic leading pharmaceutical companies engaged in the imitation and innovation of transdermal high-end preparations, focusing on scalp patches, anticoagulant drugs and other sub-fields, the development prospects deserve attention.

     

    Demand in the Asian market is growing.

     

    Thessalus Capital specifically mentioned that China currently accounts for a quarter of the global healthcare market, and that number will continue to climb. Therefore, opportunities for opportunities in the Chinese healthcare market are abundant. In order to implement the healthy China strategy, we will vigorously develop the health industry. In addition to the traditional health care field, the pan-medical health segment, such as maternal and child care, cell repair and medical beauty, is still in its infancy, and the market potential is considerable due to the impact of various factors. It is a series of special items such as the combination of traditional Chinese medicine and modern biotechnology, supplemented by the Guangdong and Hong Kong diet and health culture products, the world's first ginseng saponin nano-micelle cosmetics, and aerospace technology extracts natural health products.

    Scan the QR code to read on your phone

    ©2019 Taishan Xin Hua Pharmaceutical Packaging Co., Ltd.   粤ICP备10208845号  Powered by www.300.cn